Error: Could not add to watchlist. X

Candriam Equities L Biotechnology

+ Watchlist
DEXLBIC:LX
3,902.22
USD
2.15
0.06%
As of 00:59:30 ET on 07/02/2015.
Volume
0
Previous Close
3,904.37
52Wk Range
2,540.93 - 4,051.95
1 Yr Return
37.88%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/02/2015)
3,902.22
Total Assets (m USD) (on 07/02/2015)
844.128
Inception Date
03/03/2010
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
RUDI VAN DEN EYNDE
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.75%
Expense Ratio
0.66%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 634.00 k 71.18 m 8.47
Biogen Inc 154.00 k 61.14 m 7.27
Amgen Inc 379.00 k 59.22 m 7.04
Regeneron Pharmaceuticals Inc 105.00 k 53.82 m 6.40
Celgene Corp 450.00 k 51.50 m 6.13
Vertex Pharmaceuticals Inc 227.00 k 29.12 m 3.46
Incyte Corp 255.00 k 28.09 m 3.34
Alexion Pharmaceuticals Inc 170.00 k 27.85 m 3.31
BioMarin Pharmaceutical Inc 198.00 k 24.86 m 2.96
Illumina Inc 97.00 k 19.99 m 2.38
Profile
Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.
ADDRESS
Candriam Luxembourg
136 route d'Arlon
1150 Luxembourg
PHONE
352-254-3431